AnalystsCarly KenselaarCarly Kenselaar's Stock Forecasts
AnalystsCarly Kenselaar
Sectors:
Industries:
Analyst Ranking
Top 30%
#1484 out of 5069 analysts
Average Return
+86.25%
Win Rate
100%6 out of 6
Risk vs Reward
Poor
Good
Carly Kenselaar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | +161.76% | $7.40 | $19.37 | 2023-12-05 - 2024-12-04 | Strong Buy |
Travere Therapeutics IncTVTX | +97.09% | $10.98 | $21.64 | 2024-09-06 - 2025-09-05 | Strong Buy |
Travere Therapeutics IncTVTX | +88.15% | $14.52 | $27.32 | 2025-06-11 - 2025-10-17 | Strong Buy |
Travere Therapeutics IncTVTX | +80.59% | $14.01 | $25.30 | 2024-09-27 - 2025-09-26 | Strong Buy |
Krystal Biotech IncKRYS | +61.22% | $110.85 | $178.71 | 2023-10-12 - 2024-10-11 | Strong Buy |
Carly Kenselaar Analyst Color
Get additional color on Carly Kenselaar's coverage of popular stocks
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.